154 related articles for article (PubMed ID: 7535953)
1. [Clinical and histopathological characteristics of nonpalpable prostatic carcinoma].
Landmann C
Strahlenther Onkol; 1995 Mar; 171(3):174-5. PubMed ID: 7535953
[No Abstract] [Full Text] [Related]
2. [The prostate-specific antigen in the early recognition of prostate carcinoma].
Wolff JM; Jakse G
Dtsch Med Wochenschr; 1996 Nov; 121(48):1508-14. PubMed ID: 8983908
[No Abstract] [Full Text] [Related]
3. [Diagnostic possibilities of prostate biopsy].
Pushkar' DIu; Govorov AV
Urologiia; 2002; (6):46-51. PubMed ID: 12577581
[No Abstract] [Full Text] [Related]
4. Nonpalpable cancer of the prostate: assessment with transrectal US.
Lee F; Bronson JP; Lee F; Torp-Pedersen ST; Siders DB; Thornbury JR; McHugh TA
Radiology; 1991 Jan; 178(1):197-9. PubMed ID: 1984304
[TBL] [Abstract][Full Text] [Related]
5. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M
Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136
[TBL] [Abstract][Full Text] [Related]
6. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
[TBL] [Abstract][Full Text] [Related]
7. The role of ultrasound in prostate cancer detection in patients with an elevated prostate specific antigen level but no prostatic nodule.
Sanders RC
Md Med J; 1993 Oct; 42(10):1007-11. PubMed ID: 7505045
[TBL] [Abstract][Full Text] [Related]
8. [Screening for the early diagnosis of prostatic carcinoma in Ossola: results after 1 year of effort].
Pagani G; Iannicelli P; Rosa A; Aimè G; Ceratti G; Cobianchi PG
Arch Ital Urol Androl; 1994 Feb; 66(1):47-50. PubMed ID: 7516781
[TBL] [Abstract][Full Text] [Related]
9. [The value of PSA density for the diagnosis of prostatic cancer and for the indication of radical prostatectomy].
Doublet JD; Ciofu C; Fouret P; Gattegno B; Thibault P
Prog Urol; 1995 Apr; 5(2):211-9, 220; discussion 219-20. PubMed ID: 7536529
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer and prostate specific antigen. A Jamaican perspective.
Douglas LL
West Indian Med J; 1999 Jun; 48(2):47-9. PubMed ID: 10492600
[No Abstract] [Full Text] [Related]
11. Correlation of prostate-specific antigen and ultrasonography in the evaluation of patients with carcinoma of the prostate.
Santucci RA; Brawer MK
Semin Urol; 1994 Nov; 12(4):252-64. PubMed ID: 7533319
[No Abstract] [Full Text] [Related]
12. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
[TBL] [Abstract][Full Text] [Related]
13. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
Maffezzini M
J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
[No Abstract] [Full Text] [Related]
14. [Diagnosis, evaluation and follow-up of patients with prostatic cancer].
Jønler M; Pedersen KV
Ugeskr Laeger; 2007 May; 169(20):1889-91. PubMed ID: 17553363
[TBL] [Abstract][Full Text] [Related]
15. [The diagnosis of prostatic carcinoma].
Hammerer P; Huland H
Fortschr Med; 1991 Sep; 109(26):512-7. PubMed ID: 1723711
[TBL] [Abstract][Full Text] [Related]
16. Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients.
Spahn M; Joniau S; Gontero P; Fieuws S; Marchioro G; Tombal B; Kneitz B; Hsu CY; Van Der Eeckt K; Bader P; Frohneberg D; Tizzani A; Van Poppel H
Eur Urol; 2010 Jul; 58(1):1-7; discussion 10-1. PubMed ID: 20299147
[TBL] [Abstract][Full Text] [Related]
17. [Preoperative assessment of tumor aggressiveness in localized prostatic carcinoma].
Hammerer P; Henke RP; Hübner D; Huland H
Urologe A; 1995 Sep; 34(5):413-8. PubMed ID: 7483160
[TBL] [Abstract][Full Text] [Related]
18. [Early detection of prostatic carcinoma: Is PSA screening suitable?].
Kaulen H
Dtsch Med Wochenschr; 2003 May; 128(18):977. PubMed ID: 12755136
[No Abstract] [Full Text] [Related]
19. Prostate specimen reevaluation in patients with organ confined prostate cancer and postoperative biological recurrence.
Ravery V; De la Taille A; Toublanc M; Boccon-Gibod L; Hermieu JF; Delmas V; Boccon-Gibod L
J Urol; 1996 Jun; 155(6):1981-2. PubMed ID: 8618302
[TBL] [Abstract][Full Text] [Related]
20. [Nerve sparing radical retropubic prostatectomy and lymph node excision in prostate carcinoma].
Heidenreich A; Hammerer P
Aktuelle Urol; 2013 May; 44(3):223-42. PubMed ID: 23716024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
